MediPharm Labs Corp. (OTCMKTS:MEDIF) Sees Significant Increase in Short Interest

MediPharm Labs Corp. (OTCMKTS:MEDIFGet Rating) saw a significant growth in short interest during the month of August. As of August 31st, there was short interest totalling 2,168,700 shares, a growth of 7.7% from the August 15th total of 2,014,400 shares. Based on an average daily volume of 229,900 shares, the short-interest ratio is presently 9.4 days.

MediPharm Labs Stock Performance

Shares of MEDIF stock opened at $0.06 on Tuesday. MediPharm Labs has a fifty-two week low of $0.04 and a fifty-two week high of $0.27. The stock’s 50-day simple moving average is $0.06 and its 200-day simple moving average is $0.08.

MediPharm Labs Company Profile

(Get Rating)

MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. It formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.

Read More

Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.